Emergence and management of drug-resistant enterococcal infections

Daptomycin Treatment Failure for Vancomycin-Resistant Enterococcus faecium Infective Endocarditis: Impact of Protein Binding?

(2008) B. S Schwartz et al.   ANNALS OF PHARMACOTHERAPY

Mechanisms of Resistance to Daptomycin in Enterococcus faecium

(2008) C. I. Montero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility Testing

(2008) F. F. Arhin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL

(2008) D. A. Boyd et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States

(2008) R. E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic

(2008) L. D. Saravolatz et al.   CLINICAL INFECTIOUS DISEASES

Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline

(2008) K. B. Anthony et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin-Resistant Staphylococcus aureus: A Perfect but Geographically Limited Storm?

(2008) F. C. Tenover   CLINICAL INFECTIOUS DISEASES

Prior Environmental Contamination Increases the Risk of Acquisition of Vancomycin-Resistant Enterococci

(2008) M. Drees et al.   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Emergence of CC17Enterococcus faecium: from commensal to hospital-adapted pathogen

(2008) Janetta Top et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Oritavancin: a potential weapon in the battle against serious Gram-positive pathogens

(2008) Jared Crandon et al.   Future Microbiology

Outbreak of Enterococcus gallinarum Infections After Total Knee Arthroplasty

(2008) Michael P. Cooper et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Risk of Vancomycin-Resistant Enterococcus (VRE) Bloodstream Infection Among Patients Colonized With VRE

(2008) Chamion N. Olivier et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative

(2008) D. C. Draghi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient

(2008) G. Werner et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis

(2008) A. I. Hidron et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase

(2008) C. A. Arias et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin

(2008) C. van Nieuwkoop et al.   JOURNAL OF INFECTION

Telavancin: An Antimicrobial with a Multifunctional Mechanism of Action for the Treatment of Serious Gram-Positive Infections

(2008) Steven N Leonard et al.   PHARMACOTHERAPY

Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

(2007) Matthew E Falagas et al.   LANCET INFECTIOUS DISEASES